Company / Operating Cash Flow per Share
Day One Biopharmaceuticals, Inc. Operating Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.03
FY2025
5-year range
-$1.84 / -$0.90
FY2021-FY2025
Trend
-14.6%
vs FY2024
Sector context
#114 of 210
Health Care
What the data says
At $-1.03, Day One Biopharmaceuticals, Inc.'s operating cash flow per share ranks #114 of 210 in the Health Care sector. Operating Cash Flow per Share has fluctuated over the past 7 years, ranging from $-2.44 in FY2020 to $-0.76 in FY2019.
Based on SEC 10-K filings.
-1.03 in FY2025.
Improved from $-1.84 to $-1.03 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#114 of 210 in Health CareTop 54% of 210This company -$1.03 Sector average $5.30
▼
-119.4% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 14.6% year-over-year.
- Ranks #114 out of 210 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2019.
- Lowest operating cash flow per share in the period was in FY2020.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.03 | -14.6% |
| FY2024 | -$0.90 | +51.4% |
| FY2023 | -$1.84 | -9.7% |
| FY2022 | -$1.68 | -27.8% |
| FY2021 | -$1.31 | +46.2% |
| FY2020 | -$2.44 | -220.1% |
| FY2019 | -$0.76 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026